Delivra Health Brands Inc.
DHBUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $13 | $12 | $10 | $8 |
| % Growth | 8% | 26.4% | 20.3% | – |
| Cost of Goods Sold | $7 | $6 | $5 | $6 |
| Gross Profit | $7 | $6 | $5 | $3 |
| % Margin | 50.7% | 51.7% | 49.3% | 32% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $4 | $4 | $5 |
| SG&A Expenses | $6 | $6 | $5 | $6 |
| Sales & Mktg Exp. | $2 | $2 | $1 | $2 |
| Other Operating Expenses | $1 | $1 | $1 | $2 |
| Operating Expenses | $8 | $7 | $6 | $9 |
| Operating Income | -$1 | -$1 | -$1 | -$6 |
| % Margin | -4.6% | -5.7% | -13.9% | -78.8% |
| Other Income/Exp. Net | -$0 | $2 | $1 | -$1 |
| Pre-Tax Income | -$1 | $1 | -$0 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | $1 | -$0 | -$7 |
| % Margin | -6.5% | 7.1% | -1.9% | -86.1% |
| EPS | -0.028 | 0.031 | -0.007 | -0.28 |
| % Growth | -191.2% | 520.5% | 97.4% | – |
| EPS Diluted | -0.028 | 0.031 | -0.007 | -0.28 |
| Weighted Avg Shares Out | 31 | 29 | 25 | 25 |
| Weighted Avg Shares Out Dil | 31 | 29 | 25 | 25 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $2 |
| EBITDA | $0 | $2 | $1 | -$4 |
| % Margin | 1.1% | 19% | 14.3% | -52.3% |